Radenbach, K., Retzlik, J., Meyer-Rotz, S. H., Wolff-Menzler, C., Wolff, J., Esselmann, H., Godemann, F., Riemenschneider, M., Wiltfang, J. and Jessen, F. (2017). Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia. Normative definition of personnel requirements. Nervenarzt, 88 (9). S. 1010 - 1020. NEW YORK: SPRINGER. ISSN 1433-0407

Full text not available from this repository.

Abstract

Dementia is of increasing medical and societal relevance. Hospitalization of dementia patients is mostly due to behavioral and psychological symptoms of dementia (BPSD). There is a need for sufficient qualified personnel in hospitals in order to be able to effectively treat these symptoms. This study aims at identifying the personnel requirements for guideline-conform, evidence-based inpatient treatment concepts for patients with BPSD and to compare these with the resources defined by the German psychiatric personnel regulations (Psych-PV). Furthermore, it was the aim to identify how often patients with dementia received non-pharmacological therapy during inpatient treatment. Based on the current scientific evidence for treatment of BPSD, a schedule for a multimodal non-pharmacological treatment was defined and based on this the corresponding personnel requirements were calculated. Using the treatment indicators in psychiatry and psychosomatics (VIPP) database as a reference, it was calculated on what proportion of treatment days patients were classified into G1 according to the German Psych-PV and at least once received more than two treatment units per week. For the implementation of a guideline-oriented and evidence-based treatment plan, a higher need for personnel resources than that provided by the Psych-PV was detected in all areas. Currently patients with dementia who received at least more than two treatment units per week during inpatient hospitalization, were classified into G1 according to German Psych-PV on 17.9 % of treatment days. Despite evidence for the efficacy of non-pharmacological treatment measures on BPSD, these forms of treatment cannot be sufficiently provided under the current conditions. The realization of a new quality controlled therapeutic concept is necessary to enable optimized treatment of patients with BPSD.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Radenbach, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Retzlik, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Meyer-Rotz, S. H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolff-Menzler, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolff, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Esselmann, H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Godemann, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Riemenschneider, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiltfang, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jessen, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-219850
DOI: 10.1007/s00115-016-0195-9
Journal or Publication Title: Nervenarzt
Volume: 88
Number: 9
Page Range: S. 1010 - 1020
Date: 2017
Publisher: SPRINGER
Place of Publication: NEW YORK
ISSN: 1433-0407
Language: German
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
NONPHARMACOLOGICAL TREATMENT; OLDER-ADULTS; AGITATION; EFFICACY; TRIAL; CAREMultiple languages
Clinical Neurology; PsychiatryMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/21985

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item